Cutting-Edge Infection Research Hub

Explore peer-reviewed studies on antimicrobial resistance, sterilization protocols, and outbreak management

Research Articles

The Triple Threat: Could Combining Vedolizumab, Ustekinumab, and Tofacitinib Revolutionize Ulcerative Colitis Treatment?

Exploring the potential of vedolizumab, ustekinumab, and tofacitinib triple therapy for ulcerative colitis treatment through mechanisms, evidence, and future directions.

Connor Hughes
Oct 22, 2025

Popular Articles